cefuroxime has been researched along with Cochlear Hearing Loss in 3 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare ceftriaxone with cefuroxime for the treatment of meningitis, we conducted a study in which 106 children with acute bacterial meningitis were randomly assigned to receive either ceftriaxone (100 mg per kilogram of body weight per day, administered intravenously once daily; n = 53) or cefuroxime (240 mg per kilogram per day, administered intravenously in four equal doses; n = 53)." | 9.06 | A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. ( Auckenthaler, R; Bernath, O; Cheseaux, JJ; Gianella-Borradori, A; Pfenninger, J; Schaad, UB; Suter, S; Wedgwood, J, 1990) |
| "To compare ceftriaxone with cefuroxime for the treatment of meningitis, we conducted a study in which 106 children with acute bacterial meningitis were randomly assigned to receive either ceftriaxone (100 mg per kilogram of body weight per day, administered intravenously once daily; n = 53) or cefuroxime (240 mg per kilogram per day, administered intravenously in four equal doses; n = 53)." | 5.06 | A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. ( Auckenthaler, R; Bernath, O; Cheseaux, JJ; Gianella-Borradori, A; Pfenninger, J; Schaad, UB; Suter, S; Wedgwood, J, 1990) |
| "Early treatment of profound bilateral sensorineural hearing loss with cochlear implantation has become routine, resulting in an increased proportion of children implanted at younger ages." | 1.39 | The management of acute mastoiditis in children with cochlear implants: saving the device. ( Cushing, SL; Gordon, KA; James, AL; Osborn, HA; Papsin, BC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osborn, HA | 1 |
| Cushing, SL | 1 |
| Gordon, KA | 1 |
| James, AL | 1 |
| Papsin, BC | 1 |
| Stein, LK | 1 |
| Boyer, KM | 1 |
| Schaad, UB | 1 |
| Suter, S | 1 |
| Gianella-Borradori, A | 1 |
| Pfenninger, J | 1 |
| Auckenthaler, R | 1 |
| Bernath, O | 1 |
| Cheseaux, JJ | 1 |
| Wedgwood, J | 1 |
1 trial available for cefuroxime and Cochlear Hearing Loss
| Article | Year |
|---|---|
A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children.
Topics: Adolescent; Bacterial Infections; Ceftriaxone; Cefuroxime; Cephalosporins; Cerebrospinal Fluid; Chil | 1990 |
2 other studies available for cefuroxime and Cochlear Hearing Loss
| Article | Year |
|---|---|
The management of acute mastoiditis in children with cochlear implants: saving the device.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cefu | 2013 |
Progress in the prevention of hearing loss in infants.
Topics: Ceftriaxone; Cefuroxime; Child, Preschool; Dexamethasone; Haemophilus influenzae; Hearing Disorders; | 1994 |